Matches in SemOpenAlex for { <https://semopenalex.org/work/W4291291214> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- W4291291214 endingPage "S58" @default.
- W4291291214 startingPage "S58" @default.
- W4291291214 abstract "Identify potential biomarkers that are indicative of doping in equine plasma through statistical analysis of metabolomics data. The purpose of metabolomics is to detect endogenous changes in molecular entities, such as metabolites and adducts, that are indicative of challenges to the system (Fiehn et al., Metabolomics, 2015, 11, 1036–1040). These challenges to the system may include things such as doping, disease and environmental changes. Doping is an ever-growing field due to the changing nature of new and popular agents. For the racing industry, any performance altering agents are prohibited to maintain the welfare of athletes involved and the integrity of the sport and breeding industry (Cawley et al., Drug Testing and Analysis, 2017, 9, 1441–1447). Therefore, an alternative approach to conventional detection methods is essential for the decreasing the bottleneck that is the introduction of new compounds into routine screening efforts. Using only 100 μL of equine plasma, a rapid protein precipitation method was developed for the analysis of endogenous compounds. The IMTAKT Intrada Amino Acid column (100 mm × 2 mm, 3 μm) was able to separate dopamine-related compounds. The method used positive and negative ionisation mode with an 11-minute gradient method on the Agilent 1290 Infinity II LC system coupled to an Agilent 6545 QTOF mass spectrometer. A substantial reference population study was completed to assess basal concentrations of endogenous compounds of interest. A 12-horse administration study of Stalevo® (800 mg levodopa, 200 mg carbidopa, 1600 mg entacapone) was analysed. Agilent Technologies’ Profinder was used to complete a batch recursive feature extraction of the data. The statistical analysis included longitudinal profiling and identification of significant entities through volcano plot analysis, principal component analysis and heatmap visualisation. Biomarker quality was determined using a ‘best biomarker quality (BBQ)’ assessment. The LC-QTOF-MS method was successfully with respect to the quantification of 3-methoxytyrosine. The reference population study revealed variable levels of 3-methoxytyrosine in the population thus monitoring through individual reference limits was proposed. The longitudinal profiling approach, using 3-methoxytyrosine as an up-regulated biomarker, was proven to be more sensitive than a threshold proposed from a population. The untargeted approach using Profinder extracted a wealth of data across the administration study. The statistical analysis was able to determine significant biomarkers. The most significant biomarkers were investigated and attempted to be identified through database searching and confirmation with reference standards. An individualised reference limit approach using longitudinal profiling allowed for raceday control of levodopa misuse within the equine athlete. The untargeted metabolomics method provided an interesting alternative to conventional detection methods thus enabling the identification of biomarkers that are indicative of doping. Biomarker ratios were investigated to provide more statistical power than a single biomarker. Further work investigating an orthogonal approach using a reverse phase analytical method would allow for wider coverage of the metabolome. Doping continues to be a threat to the integrity of horse racing and thus new detection methods, such as metabolomics and statistical profiling, must be implemented to combat this challenge. 3-methoxytyrosine was identified to be a viable up-regulated biomarker for doping of levodopa. An untargeted metabolomics approach enabled the detection of further biomarkers thus allowing for a more statistically powerful biomarker ratio to be investigated." @default.
- W4291291214 created "2022-08-14" @default.
- W4291291214 creator A5004694318 @default.
- W4291291214 creator A5011712793 @default.
- W4291291214 creator A5014938994 @default.
- W4291291214 creator A5054111036 @default.
- W4291291214 creator A5062608950 @default.
- W4291291214 date "2022-09-01" @default.
- W4291291214 modified "2023-10-05" @default.
- W4291291214 title "A statistical focus on doping using a metabolomics approach" @default.
- W4291291214 doi "https://doi.org/10.1016/j.toxac.2022.06.072" @default.
- W4291291214 hasPublicationYear "2022" @default.
- W4291291214 type Work @default.
- W4291291214 citedByCount "0" @default.
- W4291291214 crossrefType "journal-article" @default.
- W4291291214 hasAuthorship W4291291214A5004694318 @default.
- W4291291214 hasAuthorship W4291291214A5011712793 @default.
- W4291291214 hasAuthorship W4291291214A5014938994 @default.
- W4291291214 hasAuthorship W4291291214A5054111036 @default.
- W4291291214 hasAuthorship W4291291214A5062608950 @default.
- W4291291214 hasBestOaLocation W42912912141 @default.
- W4291291214 hasConcept C185592680 @default.
- W4291291214 hasConcept C21565614 @default.
- W4291291214 hasConcept C2908647359 @default.
- W4291291214 hasConcept C43617362 @default.
- W4291291214 hasConcept C71924100 @default.
- W4291291214 hasConcept C99454951 @default.
- W4291291214 hasConceptScore W4291291214C185592680 @default.
- W4291291214 hasConceptScore W4291291214C21565614 @default.
- W4291291214 hasConceptScore W4291291214C2908647359 @default.
- W4291291214 hasConceptScore W4291291214C43617362 @default.
- W4291291214 hasConceptScore W4291291214C71924100 @default.
- W4291291214 hasConceptScore W4291291214C99454951 @default.
- W4291291214 hasIssue "3" @default.
- W4291291214 hasLocation W42912912141 @default.
- W4291291214 hasOpenAccess W4291291214 @default.
- W4291291214 hasPrimaryLocation W42912912141 @default.
- W4291291214 hasRelatedWork W1531601525 @default.
- W4291291214 hasRelatedWork W2003174742 @default.
- W4291291214 hasRelatedWork W2319480705 @default.
- W4291291214 hasRelatedWork W2384464875 @default.
- W4291291214 hasRelatedWork W2606230654 @default.
- W4291291214 hasRelatedWork W2607424097 @default.
- W4291291214 hasRelatedWork W2748952813 @default.
- W4291291214 hasRelatedWork W2899084033 @default.
- W4291291214 hasRelatedWork W2948807893 @default.
- W4291291214 hasRelatedWork W2778153218 @default.
- W4291291214 hasVolume "34" @default.
- W4291291214 isParatext "false" @default.
- W4291291214 isRetracted "false" @default.
- W4291291214 workType "article" @default.